Abstract

IntroductionSmooth muscle tumors of uncertain malignant potential represent a histologically heterogeneous group of uterine smooth muscle tumors that cannot be diagnosed as either benign or malignant. Smooth muscle tumors of uncertain malignant potential are usually clinically benign, but should be considered tumors of low malignant potential because they can occasionally recur or metastasize to distant sites.Case presentationWe report the case of a 62-year-old Mongol woman diagnosed with a retroperitoneal smooth muscle tumor of uncertain malignant potential and lung metastasis, with a history of prior hysterectomy. The case was initially misdiagnosed as retroperitoneal sarcoma, and our patient received chemotherapy. However, no interval change in the size of the retroperitoneal mass and metastatic lung nodules was seen over a period of at least five years. She underwent partial resection of the retroperitoneal mass for the purposes of debulking and establishing a histopathological diagnosis. The diagnosis of the retroperitoneal mass was then confirmed as a smooth muscle tumor of uncertain malignant potential.ConclusionSmooth muscle tumors of uncertain malignant potential have an unpredictable clinical course, and relapses generally appear to occur after a long disease-free interval of up to several years. Therefore, patients diagnosed with smooth muscle tumors of uncertain malignant potential should receive long-term follow-up.

Highlights

  • Smooth muscle tumors of uncertain malignant potential represent a histologically heterogeneous group of uterine smooth muscle tumors that cannot be diagnosed as either benign or malignant

  • Smooth muscle tumors of uncertain malignant potential have an unpredictable clinical course, and relapses generally appear to occur after a long disease-free interval of up to several years

  • Patients diagnosed with smooth muscle tumors of uncertain malignant potential should receive long-term follow-up

Read more

Summary

Conclusion

On the basis of our experience and review of the literature, relapses appear to occur generally after a long diseasefree interval of up to several years. In the patients with STUMPs, a long-term, close follow-up is required. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Author details 1Division of Medical Oncology, Department of Internal Medicine, Uijeongbu St Mary’s Hospital, Kyonggi-do, Korea. HSW and HGC collected clinical data and performed the literature review. All authors read and approved the final manuscript. Competing interests The authors declare that they have no competing interests

Introduction
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call